← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 30, 2020Last known activity
May 23, 2023
Acquired by Ironwood Pharmaceuticals on Jun 16, 2023
Timeline
2010s
- Jun 1, 2019
VectivBio AG— Founded
2020s
- Jun 16, 2023
Ironwood Pharmaceuticals— Acquired By
Drugs by trial phase (2 distinct, 8 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Recent trials (16)
- NCT06002555Lead sponsorPhase 1May 23, 2023
- NCT06002555Study directorPhase 1May 23, 2023
- NCT05995704Lead sponsorPhase 1Mar 2, 2023
- NCT05995704Study directorPhase 1Mar 2, 2023
- NCT05706623Lead sponsorPhase 1Jan 30, 2023
- NCT05706623Study directorPhase 1Jan 30, 2023
- NCT05415410Study directorPhase 2May 25, 2022
- NCT05415410Lead sponsorPhase 2May 25, 2022
- NCT05018286Lead sponsorPhase 3Jul 13, 2021
- NCT05018286Study directorPhase 3Jul 13, 2021
- NCT04964986Study directorPhase 2Jun 14, 2021
- NCT04964986Lead sponsorPhase 2Jun 14, 2021
- NCT04627025Study directorPhase 3Jan 26, 2021
- NCT04627025Lead sponsorPhase 3Jan 26, 2021
- NCT04699032Lead sponsorPhase 1Nov 30, 2020
Details
- Founded
- Basel, CH Jun 1, 2019
- Last known activity
- May 23, 2023